Trial intelligence / Profile preview

Vitamin D3 – Omega-3 – Home Exercise – HeALTHy Ageing and Longevity

2012-001249-41Phase 3Active

Sponsor
University Hospital Zurich
Start
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of cholecalciferol, docosahexaenoic acid and eicosapentaenoic acid in Fragility, sponsored by University Hospital Zurich. Started Oct 2012; status: active.

02

Drugs

cholecalciferoldocosahexaenoic acideicosapentaenoic acid
03

Conditions

Fragility

Beyond the preview

Go deeper on 2012-001249-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001249-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call